Goldman Sachs’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $238K | Sell |
|
|||||
|
2018
Q2 | $453K | Sell |
|
|||||
|
2018
Q1 | $3.45M | Buy |
|
|||||
|
2017
Q4 | $3.21M | Sell |
|
|||||
|
2017
Q3 | $5.03M | Buy |
|
|||||
|
2017
Q2 | $4.96M | Buy |
|
|||||
|
2017
Q1 | $4.18M | Buy |
|
|||||
|
2016
Q4 | $3.85M | Buy |
|
|||||
|
2016
Q3 | $3.28M | Buy |
|
|||||
|
2016
Q2 | $2.86M | Buy |
|
|||||
|
2016
Q1 | $326K | Buy |
|
|||||
|
2015
Q4 | $336K | Sell |
|
|||||
|
2015
Q3 | $4.03M | Buy |
|
|||||
|
2015
Q2 | $1.18M | Buy |
|
|||||
|
2015
Q1 | $447K | Sell |
|
|||||
|
2014
Q4 | $917K | Sell |
|
|||||
|
2014
Q3 | $2.28M | Buy |
|
|||||
|
2014
Q2 | $2.52M | Buy |
|
|||||
|
2014
Q1 | $873K | Sell |
|
|||||
|
2013
Q4 | $7.33M | Sell |
|
|||||
|
2013
Q3 | $7.74M | Buy |
|
|||||
|
2013
Q2 | $3.99M | Buy |
|